vs
COMPASS MINERALS INTERNATIONAL INC（CMP）与COLLEGIUM PHARMACEUTICAL, INC（COLL）财务数据对比。点击上方公司名可切换其他公司
COMPASS MINERALS INTERNATIONAL INC的季度营收约是COLLEGIUM PHARMACEUTICAL, INC的1.9倍（$396.1M vs $205.4M），COLLEGIUM PHARMACEUTICAL, INC净利率更高（8.3% vs 4.7%，领先3.6%），COMPASS MINERALS INTERNATIONAL INC同比增速更快（28.9% vs 12.9%），COLLEGIUM PHARMACEUTICAL, INC自由现金流更多（$122.4M vs $-59.8M），过去两年COLLEGIUM PHARMACEUTICAL, INC的营收复合增速更高（19.1% vs 4.3%）
指南针矿产国际是一家美国上市矿产企业，总部位于堪萨斯州欧弗兰帕克，是盐、氯化镁和硫酸钾等产品的领先生产商。公司面向北美和英国客户供应经处理与未经处理的散装道路除冰盐，同时向全球种植者提供植物营养产品，此外也生产民用除冰、水质调节产品及相关商用产品。
Collegium制药是一家专科制药企业，专注于研发和商业化具备滥用威慑特性的创新疼痛管理疗法，主要面向美国市场，推出适用于慢性疼痛患者的缓释镇痛产品，服务覆盖基层及专科医疗领域的医护人员。
CMP vs COLL — 直观对比
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $396.1M | $205.4M |
| 净利润 | $18.6M | $17.0M |
| 毛利率 | 16.0% | 62.5% |
| 营业利润率 | 9.2% | 29.6% |
| 净利率 | 4.7% | 8.3% |
| 营收同比 | 28.9% | 12.9% |
| 净利润同比 | 178.8% | 35.3% |
| 每股收益（稀释后） | $0.43 | $0.48 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $396.1M | $205.4M | ||
| Q3 25 | $227.5M | $209.4M | ||
| Q2 25 | $214.6M | $188.0M | ||
| Q1 25 | $494.6M | $177.8M | ||
| Q4 24 | $307.2M | $181.9M | ||
| Q3 24 | $208.8M | $159.3M | ||
| Q2 24 | $202.9M | $145.3M | ||
| Q1 24 | $364.0M | $144.9M |
| Q4 25 | $18.6M | $17.0M | ||
| Q3 25 | $-7.2M | $31.5M | ||
| Q2 25 | $-17.0M | $12.0M | ||
| Q1 25 | $-32.0M | $2.4M | ||
| Q4 24 | $-23.6M | $12.5M | ||
| Q3 24 | $-48.3M | $9.3M | ||
| Q2 24 | $-43.6M | $19.6M | ||
| Q1 24 | $-38.9M | $27.7M |
| Q4 25 | 16.0% | 62.5% | ||
| Q3 25 | 16.9% | 61.7% | ||
| Q2 25 | 19.2% | 57.7% | ||
| Q1 25 | 15.5% | 54.8% | ||
| Q4 24 | 11.2% | 54.0% | ||
| Q3 24 | 9.3% | 60.8% | ||
| Q2 24 | 16.1% | 62.5% | ||
| Q1 24 | 19.7% | 63.1% |
| Q4 25 | 9.2% | 29.6% | ||
| Q3 25 | 5.3% | 29.7% | ||
| Q2 25 | 7.4% | 18.7% | ||
| Q1 25 | -0.6% | 12.2% | ||
| Q4 24 | 0.2% | 20.9% | ||
| Q3 24 | -14.3% | 21.9% | ||
| Q2 24 | 2.9% | 32.7% | ||
| Q1 24 | -10.8% | 34.1% |
| Q4 25 | 4.7% | 8.3% | ||
| Q3 25 | -3.2% | 15.0% | ||
| Q2 25 | -7.9% | 6.4% | ||
| Q1 25 | -6.5% | 1.4% | ||
| Q4 24 | -7.7% | 6.9% | ||
| Q3 24 | -23.1% | 5.9% | ||
| Q2 24 | -21.5% | 13.5% | ||
| Q1 24 | -10.7% | 19.1% |
| Q4 25 | $0.43 | $0.48 | ||
| Q3 25 | — | $0.84 | ||
| Q2 25 | $-0.41 | $0.34 | ||
| Q1 25 | $-0.77 | $0.07 | ||
| Q4 24 | $-0.57 | $0.36 | ||
| Q3 24 | $-1.17 | $0.27 | ||
| Q2 24 | $-1.05 | $0.52 | ||
| Q1 24 | $-0.94 | $0.71 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $46.7M | $386.7M |
| 总债务越低越好 | $890.0M | — |
| 股东权益账面价值 | $260.5M | $301.7M |
| 总资产 | $1.5B | $1.7B |
| 负债/权益比越低杠杆越低 | 3.42× | — |
8季度趋势，按日历期对齐
| Q4 25 | $46.7M | $386.7M | ||
| Q3 25 | $59.7M | $285.9M | ||
| Q2 25 | $79.4M | $222.2M | ||
| Q1 25 | $49.5M | $197.8M | ||
| Q4 24 | $45.8M | $162.8M | ||
| Q3 24 | $20.2M | $120.0M | ||
| Q2 24 | $12.8M | $271.6M | ||
| Q1 24 | $38.3M | $318.0M |
| Q4 25 | $890.0M | — | ||
| Q3 25 | $839.8M | — | ||
| Q2 25 | $833.4M | — | ||
| Q1 25 | $807.6M | — | ||
| Q4 24 | $974.4M | — | ||
| Q3 24 | $921.2M | — | ||
| Q2 24 | $875.1M | — | ||
| Q1 24 | $877.2M | — |
| Q4 25 | $260.5M | $301.7M | ||
| Q3 25 | $234.1M | $274.8M | ||
| Q2 25 | $249.8M | $232.2M | ||
| Q1 25 | $236.5M | $234.4M | ||
| Q4 24 | $263.0M | $228.8M | ||
| Q3 24 | $316.6M | $234.3M | ||
| Q2 24 | $352.1M | $216.6M | ||
| Q1 24 | $400.4M | $222.2M |
| Q4 25 | $1.5B | $1.7B | ||
| Q3 25 | $1.5B | $1.6B | ||
| Q2 25 | $1.5B | $1.6B | ||
| Q1 25 | $1.5B | $1.6B | ||
| Q4 24 | $1.7B | $1.7B | ||
| Q3 24 | $1.6B | $1.6B | ||
| Q2 24 | $1.6B | $1.1B | ||
| Q1 24 | $1.7B | $1.1B |
| Q4 25 | 3.42× | — | ||
| Q3 25 | 3.59× | — | ||
| Q2 25 | 3.34× | — | ||
| Q1 25 | 3.41× | — | ||
| Q4 24 | 3.70× | — | ||
| Q3 24 | 2.91× | — | ||
| Q2 24 | 2.49× | — | ||
| Q1 24 | 2.19× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-37.0M | $123.0M |
| 自由现金流经营现金流 - 资本支出 | $-59.8M | $122.4M |
| 自由现金流率自由现金流/营收 | -15.1% | 59.6% |
| 资本支出强度资本支出/营收 | 5.8% | 0.3% |
| 现金转化率经营现金流/净利润 | -1.99× | 7.25× |
| 过去12个月自由现金流最近4个季度 | $94.1M | $327.6M |
8季度趋势，按日历期对齐
| Q4 25 | $-37.0M | $123.0M | ||
| Q3 25 | $-6.9M | $78.4M | ||
| Q2 25 | $21.8M | $72.4M | ||
| Q1 25 | $186.9M | $55.4M | ||
| Q4 24 | $-4.1M | $84.6M | ||
| Q3 24 | $-12.7M | $-9.0M | ||
| Q2 24 | $-6.8M | $67.4M | ||
| Q1 24 | $86.2M | $61.9M |
| Q4 25 | $-59.8M | $122.4M | ||
| Q3 25 | $-22.8M | $78.3M | ||
| Q2 25 | $3.8M | $72.4M | ||
| Q1 25 | $172.9M | $54.6M | ||
| Q4 24 | $-25.9M | $84.1M | ||
| Q3 24 | $-33.6M | $-9.2M | ||
| Q2 24 | $-21.5M | $67.1M | ||
| Q1 24 | $56.2M | $61.4M |
| Q4 25 | -15.1% | 59.6% | ||
| Q3 25 | -10.0% | 37.4% | ||
| Q2 25 | 1.8% | 38.5% | ||
| Q1 25 | 35.0% | 30.7% | ||
| Q4 24 | -8.4% | 46.2% | ||
| Q3 24 | -16.1% | -5.8% | ||
| Q2 24 | -10.6% | 46.2% | ||
| Q1 24 | 15.4% | 42.3% |
| Q4 25 | 5.8% | 0.3% | ||
| Q3 25 | 7.0% | 0.1% | ||
| Q2 25 | 8.4% | 0.0% | ||
| Q1 25 | 2.8% | 0.4% | ||
| Q4 24 | 7.1% | 0.3% | ||
| Q3 24 | 10.0% | 0.2% | ||
| Q2 24 | 7.2% | 0.2% | ||
| Q1 24 | 8.2% | 0.4% |
| Q4 25 | -1.99× | 7.25× | ||
| Q3 25 | — | 2.49× | ||
| Q2 25 | — | 6.05× | ||
| Q1 25 | — | 22.92× | ||
| Q4 24 | — | 6.75× | ||
| Q3 24 | — | -0.96× | ||
| Q2 24 | — | 3.44× | ||
| Q1 24 | — | 2.23× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CMP
| Highway Deicing Salt | $210.8M | 53% |
| Consumer Industrial Salt | $120.7M | 30% |
| Plant Nutrition | $60.8M | 15% |
| Transferred Over Time | $2.8M | 1% |
| Other | $1.0M | 0% |
COLL
暂无分部数据
